PTJ
CBST

Paul Tudor Jones’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Paul Tudor Jones’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-3,348
Closed -$231K – 1586
2013
Q4 		$231K Buy
+3,348
New +$217K 0.01% 1032

Other funds holding CBST

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Paul Tudor Jones's CBST Position: Q1 2014 in Review

Paul Tudor Jones sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2014, closing a stake of 3,348 shares — an estimated $231K sold.

Paul Tudor Jones first reported a position in CBST in Q4 2013 and held it in 1 quarter. The position peaked at $231K in Q4 2013. 276 funds tracked by Wall St. Rank hold CBST as of Q1 2014.

  • Paul Tudor Jones reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Paul Tudor Jones sold 3,348 CUBIST PHARMACEUTICALS INC shares in Q1 2014, an estimated $231K.
  • Paul Tudor Jones first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2013 and held it in 1 quarter.
  • Paul Tudor Jones's CUBIST PHARMACEUTICALS INC position peaked at $231K in Q4 2013.
  • 276 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2014.

Based on Tudor Investment Corp's 13F filing for Q1 2014, filed 15 May 2014.